The Ebola virus and it’s close relative the Marburg virus are members of the Filoviridae family. These viruses are the causative agents of severe hemorrhagic fever, a disease with a fatality rate of up to 90% [12]. The Ebola virus infects mainly the capillary endothelium and several types of immune cells. The symptoms of Ebola infection include maculopapular rash, petechiae, purpura, ecchymoses, dehydration and hematomas [13].
Since Ebola was first described in 1976, there have been several epidemics of this disease. Hundreds of people have died because of Ebola infections, mainly in Zaire, Sudan, Congo and Uganda [14]. In addition, several fatalities have occurred because of accidents in laboratories working with the virus [15]. Currently, a number of scientists claim that terrorists may use Ebola as a biological weapon [14, 16].
In the 3D model presented in this study, Ebola-encoded structures are shown in maroon, and structures from human cells are shown in grey. The Ebola model is based on
The Ebola virion is rod-shaped or
Testimonial
Lewis L. Sadler, MA, MSc Chief Science Officer, Visible Productions, Inc.
Research Assistant Professor, Director NeuroImage Science Laboratory Department of Neurosurgery, College of Medicine University of Illinois at Chicago.
Cast
- Project manager, 3D-visualizator, 3D-technologist, molecular modeller, designer
- Ivan Konstantinov
- Researcher, scientific advisor
- YuryStefanov (Ph. D)
- 3D-modeller:
- Alex Kovalevsky
- Molecular modeller, researcher, consultant
- Anastasya Bakulina (Ph. D)
- Web-technologist
- Kirill Grishanin
- We are grateful to Dr. Ronald Harty for useful comments and providing important information
- We also want to thank Dmitry Barbanel and Amy Gordon for their help in the preparation of the poster
Date: Feb 03, 2012
References
-
, Arch Virol Suppl. 1999;15:159-69.
-
, J Virol. 2009 Sep;83(18):9596-601. Epub 2009 Jul 8.
-
, J Virol. 1997 Mar;71(3):1922-30.
-
, J Gen Virol. 1997 Aug;78 ( Pt 8):1907-11.
-
, J Mol Biol. 2000 Jun 30;300(1):103-12.
-
, J Struct Biol. 2009 Aug;167(2):136-44. Epub 2009 May 15.
-
, J Vet Med Sci. 2005 Mar;67(3):325-8.
-
, J Gen Virol. 1999 Feb;80 ( Pt 2):355-62.
-
, Virulence. 2010 Nov-Dec;1(6):526-31. Epub 2010 Nov 1.
-
, Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):624-9. Epub 2007 Jan 3.
-
, Virol J. 2005 Dec 20;2:92.
-
, Hum Vaccin. 2010 Jun;6(6):439-49. Epub 2010 Jun 1.
-
, Clin Lab Med. 2010 Mar;30(1):161-77.
-
, Lancet. 2011 Mar 5;377(9768):849-62.
-
, The Seattle Times, March 28, 2009 at 12:00 AM
-
, Euro Surveill. 2004 Dec 15;9(12):E11-2.
-
, Mol Aspects Med. 2008 Jun;29(3):151-85. Epub 2007 Oct 22.
-
, EMBO J. 2003 Apr 1;22(7):1707-15.
-
, Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19123-7. Epub 2006 Dec 4.
-
, Intervirology. 2010;53(5):362-78. Epub 2010 Jun 15.
-
, Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17486-91. Epub 2011 Oct 10.
-
, Mol Cell Proteomics. 2010 Dec;9(12):2690-703. Epub 2010 Aug 11.
-
, Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2662-7.
-
, Nature. 2006 Jun 15;441(7095):847-52. Epub 2006 May 24
-
, Science. 2004 Mar 19;303(5665):1866-70. Epub 2004 Feb 5.
-
, J Virol. 2005 Nov;79(21):13421-33.
-
, J Virol. 2006 Jun;80(11):5156-67.
-
, FEMS Microbiol Lett. 2004 Apr 15;233(2):179-86.
-
, Virology. 2006 Jan 5;344(1):64-70.
-
, J Virol. 2006 Apr;80(8):3743-51.
-
, J Virol. 2007 Sep;81(17):9519-24. Epub 2007 Jun 13.
-
, Unpublished
-
, Virus Res. 2009 Mar;140(1-2):8-14. Epub 2008 Dec 16.
-
, PLoS Pathog. 2010 Apr 29;6(4):e1000875.
-
, Mol Cell. 2002 Aug;10(2):307-16.
-
, Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6.
-
, J Virol. 2001 Jun;75(11):5205-14.
-
, PLoS One. 2012;7(1):e29608. Epub 2012 Jan 11.
-
, PLoS Biol. 2011 Nov;9(11):e1001196. Epub 2011 Nov 15.
- ,
